Content about Immunosuppressants

August 1, 2011

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for injection under the skin to treat rheumatoid arthritis, Bristol said Friday.

July 22, 2011

A panel of experts at the Food and Drug Administration has recommended that the agency approve a drug made by Johnson & Johnson as a treatment for ulcerative colitis in children.

June 16, 2011

The Food and Drug Administration has approved a new drug for preventing organ rejection in kidney transplant patients, the agency said Wednesday.

May 11, 2011

Patients with moderate to severe rheumatoid arthritis who respond to 12 weeks of treatment with a drug made by UCB are more likely to show improvement in their condition in the long run, according to results of a study published in the Journal of Rheumatology.

May 6, 2011

The Food and Drug Administration has approved a drug made by Novartis as the first treatment for advanced pancreatic neuroendocrine tumors, Novartis said Thursday.

April 18, 2011

The Food and Drug Administration has approved a drug made by Genentech for treating a rare and severe form of arthritis that affects children, Genentech said.

April 14, 2011

The Food and Drug Administration has received reports of a rare and usually deadly cancer in patients using a class of biotech drugs to treat autoimmune and inflammatory diseases, the agency said Thursday.

February 11, 2011

The Food and Drug Administration announced Friday the approval of Waltham, Mass.-based Thermo Fisher’s QMS Everolimus Immunoassay, a test that monitors the blood for levels of Novartis’ drug Zortress (everolimus).

February 4, 2011

A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

December 9, 2010

A new three-drug combination may work as a front-line treatment for cancer of the plasma cells, according to an early-stage clinical study.

December 7, 2010

The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.

December 7, 2010

U.S. generic drug maker Watson Pharmaceuticals and Indian drug maker Natco Pharma will work together to develop and commercialize a generic drug used for bone marrow disorders, the two companies said Tuesday.

November 7, 2010

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

September 29, 2010

The biotech division of Johnson & Johnson is hoping to expand the use of a...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 20, 2010

The Food and Drug Administration has approved a generic treatment for organ transplant patients....

July 5, 2010

The Food and Drug Administration has approved a drug made by Watson Pharmaceuticals for treating...

May 20, 2010

Dr. Reddy’s Labs has launched a treatment for organ transplant patients, the Indian generic drug...

May 18, 2010

The Food and Drug Administration has approved a new biotech drug made by Roche U.S....

May 16, 2010

Sandoz got its hands on a collection of generic drug candidates as it agreed to...

March 21, 2010

The market for drugs that treat a cancer of the bone marrow will more than...

February 21, 2010

The high prices of drugs made by Johnson & Johnson and Abbott will drive the...

January 10, 2010

The Food and Drug Administration has approved a Genentech drug for treating rheumatoid arthritis, the...

January 3, 2010

A new report by Decision Resources revealed that a biological therapy with a mechanism of...

© 2014 Drug Store News. All Rights Reserved.